EMA Tightens Clock-Stop Rules To Address Impact On Drug Approval Timelines
The European Medicines Agency says that in 2022, the average time taken up by clock-stops exceeded the average time of drug assessment.
The European Medicines Agency says that in 2022, the average time taken up by clock-stops exceeded the average time of drug assessment.